Insider · CIK 0001790174
Patrick Berard
Files at LKQ (LKQ CORP). First filing -, latest -.
In brief
Patrick Berard files SEC Form 4 as director at LKQ (LKQ CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Patrick Berard has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 7, 2024 | LKQ LKQ CORP | 867 0.00% of outstanding | $39k | May 7, 2024 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | LKQ LKQ CORP | FTax withholding Common Stock | -1,253 | $28.93 | $36k | 18,378 | May 8, 2026 |
| May 7, 2025 | LKQ LKQ CORP | AGrant or award Common Stock | +4,176 | $0.00 | $0 | 20,743 | May 9, 2025 |
| May 7, 2025 | LKQ LKQ CORP | FTax withholding Common Stock | -1,113 | $39.52 | $44k | 19,630 | May 9, 2025 |
Questions about Patrick Berard
Answered from the filings on this page, as of the latest one.
Is Patrick Berard buying or selling?
Patrick Berard has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Patrick Berard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick Berard has 0.
Where does Patrick Berard file Form 4?
Patrick Berard has filed Form 4 at LKQ (LKQ CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.